Literature DB >> 8498519

Gastric axial forces in experimentally delayed and accelerated gastric emptying.

C M Prather1, M Camilleri, G M Thomforde, L A Forstrom, A R Zinsmeister.   

Abstract

The aim of this study was to assess the relationship between altered axial forces and gastric emptying of solids by experimentally inhibiting or stimulating gastric axial forces by intraduodenal lipid or intravenous erythromycin, respectively. In 15 healthy volunteers, we simultaneously measured gastric emptying of solids by scintigraphy, gastroduodenal motility by manometry, and forces along the longitudinal axis of the distal stomach by an axial force transducer. When 25% of the radiolabel had emptied from the stomach, subjects (n = 5 in each group) received normal saline (controls), intraduodenal lipid, or intravenous erythromycin. The test period consisted of the infusion period (10 min) and the subsequent 30 min. Lipid significantly reduced and erythromycin increased axial forces compared with control (lipid: median 0.6 N [0-1.4 interquartile range (IQR)]; erythromycin: median 18.2 N (16.5-20.5 IQR); control: median 4.7 N (3.9-5.2 IQR); P < 0.01). Similarly, antral phasic pressure activities were different relative to control. Gastric axial forces correlated significantly with gastric emptying (Spearman rank correlation = 0.86; P < 0.01). These data are consistent with the hypothesis that axial forces affect gastric emptying of solids and suggest that measurement of axial forces provides an assessment of overall gastric propulsion during the emptying of solids.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8498519     DOI: 10.1152/ajpgi.1993.264.5.G928

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Relation between cholecystokinin and antral innervation in the control of gastric emptying in the rat.

Authors:  A Higham; C Vaillant; B Yegen; D G Thompson; G J Dockray
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  Diagnostic yield of small bowel capsule endoscopy depends on the small bowel transit time.

Authors:  Jessie Westerhof; Jan J Koornstra; Reinier A Hoedemaker; Wim J Sluiter; Jan H Kleibeuker; Rinse K Weersma
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

3.  Postprandial function in gastroparesis.

Authors:  M Camilleri
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

4.  Abnormal postprandial duodenal chyme transport in patients with long standing insulin dependent diabetes mellitus.

Authors:  H N Nguyen; J Silny; S Wüller; H U Marschall; G Rau; S Matern
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

5.  Antral axial forces postprandially and after erythromycin in organic and functional dysmotilities.

Authors:  E Surrenti; M Camilleri; P P Kammer; C M Prather; A J Schei; R B Hanson
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

6.  Preclinical electrogastrography in experimental pigs.

Authors:  Jaroslav Květina; Jithinraj Edakkanambeth Varayil; Shahzad Marghoob Ali; Martin Kuneš; Jan Bureš; Ilja Tachecí; Stanislav Rejchrt; Marcela Kopáčová
Journal:  Interdiscip Toxicol       Date:  2010-06

7.  Axial forces during gastric emptying in health and models of disease.

Authors:  M Camilleri; C M Prather
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

8.  Effect of erythromycin on image quality and transit time of capsule endoscopy: a two-center study.

Authors:  Eva Niv; Ido Bonger; Olga Barkay; Zamir Halpern; Elisabeth Mahajna; Roman Depsames; Yael Kopelman; Zvi Fireman
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

9.  Differential regional effects of octreotide on human gastrointestinal motor function.

Authors:  M R von der Ohe; M Camilleri; G M Thomforde; G G Klee
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

10.  Completion rate of small bowel capsule endoscopy is higher after erythromycin compared to domperidone.

Authors:  Jessie Westerhof; Rinse K Weersma; Reinier A Hoedemaker; Jan J Koornstra
Journal:  BMC Gastroenterol       Date:  2014-09-19       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.